Company intelligence / Profile preview

CDT OIL

Naples, Florida, United Stateskeele.ac.uk ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

The company has two main clinical-stage programs that have completed Phase I trials: AZD1656 for type 2 diabetes and multiple autoimmune indications including renal transplant and Hashimoto's thyroiditis; AZD5904 for idiopathic male infertility. It also pursues licensing opportunities and new patents such as a dual active cocrystal formulation of tapinarof.

Therapeutic areas: Men's HealthEndocrinologyImmunologyDermatologyNephrologyWomen's Health
Modalities: Small moleculeCocrystal formulation
Industry: Biotech

Partnerships

AstraZenecaAgility Life Sciences CDMO partnership for oral dosage formsSarborg AI/cybernetics collaborationpotential out-licensing focus on VTAMA® patents

Beyond the preview

Go deeper on CDT OIL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDT OIL.

Explore the full profile